Can a single eye injection save sight in premature infants?

This trial investigates whether an injection of ranibizumab, a drug that blocks abnormal blood vessel growth, can effectively treat aggressive posterior retinopathy of prematurity (AP-ROP) in premature infants. AP-ROP is a fast-progressing eye condition that can lead to retinal detachment and permanent blindness if not treated quickly. The study will measure how well the disease responds to the injection, how often it comes back, and whether additional injections are needed, with the goal of improving treatment strategies for these vulnerable babies.